Macrogenics (MGNX) Net Equity Issued and Repurchased (2012 - 2023)

Macrogenics (MGNX) has reported Net Equity Issued and Repurchased for 11 consecutive years, with $616000.0 the latest figure, recorded in Q1 2023.

• In Q1 2023, Net Equity Issued and Repurchased changed N/A year-over-year to $616000.0; the TTM figure through Dec 2023 stood at $616000.0 (down 43.23% YoY), while the FY2023 annual figure was $616000.0, down 43.23% from the prior year.
• Net Equity Issued and Repurchased fell to $616000.0 in Q1 2023 per MGNX's latest filing, from $1.1 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $118.7 million in Q1 2019 and bottomed at -$38000.0 in Q4 2020.
• Historically, Net Equity Issued and Repurchased has averaged $51.1 million across 5 years, with a median of $46.8 million in 2020.
• On a YoY basis, Net Equity Issued and Repurchased climbed as much as 73.48% in 2021 and fell as far as 73.48% in 2021.
• Macrogenics' Net Equity Issued and Repurchased stood at $118.7 million in 2019, then plunged by 100.03% to -$38000.0 in 2020, then surged by 51726.32% to $19.6 million in 2021, then plunged by 94.47% to $1.1 million in 2022, then plunged by 43.23% to $616000.0 in 2023.
• Business Quant data shows MGNX's Net Equity Issued and Repurchased at $616000.0 in Q1 2023, $1.1 million in Q4 2022, and $19.6 million in Q3 2021.